Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma

Myra Langendonk(University Medical Center Groningen), Tom van Meerten(University Medical Center Groningen)

Blood Cancer Journal

March 7, 2022

10.1038/s41408-022-00631-7

Cited by 20

Related Papers

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

|The Lancet|2024|135

Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma

|International Journal of Molecular Sciences|2022|5